Analyze Diet

[The concentration changes of different phenylbutazone formulations in horse plasma].

Abstract: In a study in the horse, the disposition, the pharmacokinetic parameters and the absorption rates of 3 formulations of phenylbutazone (injection solution, powder and paste suspension) have been determined. After i.v. injection, the half-life time of phenylbutazone has been determined to be 6.6-6.7 h. After oral administration, the absorption of phenylbutazone was found to be faster after administration via stomach tube than after direct application into the mouth. The absorption rat constant of the paste suspension was found to be higher than that of the powder (1.797-2.304 h-1 vs. 0.656-1.197 h-1). The maximal plasma concentrations were attained within 0.5-3 hours with all formulations and were dose-dependent. The elimination of phenylbutazone was not dependent on the dose and formulation applied. The bioavailability of the studied powder and paste formulation was calculated to be 55.1-96.7%. Generally, the bioavailability was higher following administration of the drug via stomach tube. In some horses, the disposition pattern was atypical and delayed absorption was found. This may be due to adsorption of phenylbutazone on the food with subsequent release in the large intestine. The minimal therapeutic level of 5 micrograms/ml was attained 0.2-0.8 hours after administration of the drug and lasted 8.2-22 hours depending on the dose applied. The paste suspension of phenylbutazone may provide a good therapeutic tool for horses, which normally refuse to take powder supplemented food. At the end the authors report on their good clinical results in using Butasan-Paste with 30 ill horses.
Publication Date: 1996-06-01 PubMed ID: 8766906
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • English Abstract
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article studies how three formulations of phenylbutazone (injection, powder, and paste suspension) are distributed and absorbed in horse bodies. It provides insight into the half-life, optimal ingestion method, absorption rates, and other pharmacokinetic parameters of the drug in horses.

Methodology and Key Findings

  • The study examines the absorption rate and overall pharmacokinetics of phenylbutazone, a non-steroidal anti-inflammatory drug, in various formulations in horses.
  • Upon intravenous injection, the half-life of phenylbutazone was gauged to be between 6.6 to 6.7 hours.
  • Oral administration via a stomach tube was found to be more efficient in terms of absorption than a direct application into the horse’s mouth.
  • Among the oral formulations, the absorption rate constant of the paste suspension was markedly higher compared to the powder version.
  • The maximum plasma concentrations were obtained within 0.5 to 3 hours and were found to be dose-dependent. Regardless of its dose and formulation, phenylbutazone’s elimination did not vary.

Drug Efficiency and its Clinical Implication

  • Phenylbutazone’s bioavailability, the amount of the drug that reaches the systemic circulation intact, was estimated to be between 55.1 to 96.7% for the powder and paste formats. This percentage was higher when the drug was administered via a stomach tube.
  • In certain horses, the absorption of the drug showed an atypical pattern, with a delayed duration suggesting that the drug might have been absorbed onto the food and later released in the large intestine.
  • The least therapeutic level of 5 micrograms/ml was achieved between 0.2-0.8 hours after the drug’s administration, lasting between 8.2 to 22 hours, adjustably according to the administered dose.
  • The study suggests that the paste suspension of phenylbutazone could present an alternative to horses that refuse to consume food mixed with the powder form of the drug.
  • The authors also highlighted their positive clinical results using Butasan-Paste on 30 sick horses in their practice.

Cite This Article

APA
Keller H, Hashem A. (1996). [The concentration changes of different phenylbutazone formulations in horse plasma]. Dtsch Tierarztl Wochenschr, 103(6), 224-230.

Publication

ISSN: 0341-6593
NlmUniqueID: 7706565
Country: Germany
Language: ger
Volume: 103
Issue: 6
Pages: 224-230

Researcher Affiliations

Keller, H
  • Klinik für Pferde, Allgemeine Chirurgie und Radiologie, Freien Universität Berlin.
Hashem, A

    MeSH Terms

    • Absorption
    • Administration, Oral
    • Animals
    • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
    • Anti-Inflammatory Agents, Non-Steroidal / blood
    • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics
    • Biological Availability
    • Dose-Response Relationship, Drug
    • Female
    • Horses / blood
    • Horses / metabolism
    • Injections, Intravenous / veterinary
    • Male
    • Ointments
    • Phenylbutazone / administration & dosage
    • Phenylbutazone / blood
    • Phenylbutazone / pharmacokinetics
    • Powders
    • Solutions

    Citations

    This article has been cited 0 times.